Overman MJ, Kopetz S, McDermott RS, et al. Nivolumab ± ipilimumab in treatment (tx) of patients (pts) with metastatic colorectal cancer (mCRC) with and without high microsa tellite instability (MSI-H): CheckMate-142 interim results. J Clin Oncol.